Ultrasound-guided Selective Shoulder Block Versus Ultrasound-guided Interscalene Brachial Plexus Block, an RCT
Treatment of Postoperative Pain After Shoulder Surgery. Ultrasound-guided Block of the Axillary and Suprascapular Nerves (Selective Shoulder Block) Versus Ultrasound-guided Interscalene Brachial Plexus Block: An Observer-blinded RCT
1 other identifier
interventional
100
1 country
1
Brief Summary
This is a randomised, observer-blinded trial to compare selective shoulder block with interscalene block. Both blocks will be placed using an ultra-sound guided technique. Primary outcome measures will be postoperative pain scores and use of rescue opioids. Secondary outcome measures will be pre- and postoperative occurence of motor deficit of the arm and dyspnea, quality of sleep in the first night after surgery as measured by a numeric rating scale and overall satisfaction with pain therapy as measured by the International Pain Outcomes questionnaire and an NRS-score (0 = not satisfied at all and 10 = very satisfied). Primary and secondary outcome measures will be assessed during the first 24hours after surgery (assessment in the postanesthetic care unit (PACU) directly after admission and before discharge and in the surgical ward at 4, 8 and 24 hours after surgery). Overall satisfaction with pain therapy will be assessed 48hours after surgery. An interscalene block is a block of the plexus brachialis in the interscelene triangle (by injecting a local anesthetic around the nerve plexus). A selective shoulder block is a block of the suprascapular and axillary nerves (by injecting a local anesthetic around these nerves).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedApril 5, 2016
April 1, 2016
10 months
March 8, 2015
April 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain Score as measured by Numeric Rating Scale
24hours
Use of piritramide as documented by the PCIA (patient controlled intravenous analgesia) system
24hours
Secondary Outcomes (4)
Subjective feeling of dyspnea as measured by a numeric rating scale
24hours
Motor deficit after nerve block as measured by Medical Research Council scale
24hours
Quality of sleep in the first night after surgery as measured by a numeric rating scale
24hours
Overall satisfaction as measured by the International Pain Outcomes questionnaire
48 hours
Study Arms (2)
Interscalene block
ACTIVE COMPARATORblock of the plexus brachialis in the interscalene region with local anaesthetics
Selective shoulder block
ACTIVE COMPARATORselective block of the suprascapular nerve and the axillary nerve with local anaesthetics
Interventions
block of the plexus brachialis in the interscalene region with local anaesthetics
selective block of the suprascapular nerve and the axillary nerve with local anaesthetics
Eligibility Criteria
You may qualify if:
- elective arthroscopic shoulder surgery
- elective hospital admission for one night
- age \> 18 years and \< 75 years
- American Society of Anesthesiologists (ASA) physical status classification 1, 2 of 3.
You may not qualify if:
- pregnancy
- severe obesity ( BMI \> 35)
- severe COPD (Gold≥ 3) or restrictive (FEV1 \< 50%) lungdisease
- coagulation disorders
- diabetes mellitus
- previous injury or surgery of the involved shoulder
- pre-existing neuropathy or myopathy of the involved arm
- allergy or contra-indication for the medication used in the study
- preoperative use of opioids
- infection at the puncture site
- inability to understand or speak Dutch
- inability to understand the PCIA system
- inability to understand the NRS pain score system
- refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stessel Björnlead
Study Sites (1)
Jessaziekenhuis Hasselt
Hasselt, Limburg, 3500, Belgium
Related Publications (1)
Neuts A, Stessel B, Wouters PF, Dierickx C, Cools W, Ory JP, Dubois J, Jamaer L, Arijs I, Schoorens D. Selective Suprascapular and Axillary Nerve Block Versus Interscalene Plexus Block for Pain Control After Arthroscopic Shoulder Surgery: A Noninferiority Randomized Parallel-Controlled Clinical Trial. Reg Anesth Pain Med. 2018 Oct;43(7):738-744. doi: 10.1097/AAP.0000000000000777.
PMID: 29659438DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dirk Schoorens, MD
Jessa Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 8, 2015
First Posted
April 14, 2015
Study Start
April 1, 2015
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
April 5, 2016
Record last verified: 2016-04